Condition

Prostate Cancers clinical trials and research

• 11Clinical trials
• 10NIH research projects
• 11Countries

Newest Prostate Cancers clinical trials

All recruiting trials (11)

• High-resolution XEOS AURA 10 PET-CT imaging of removed tumor tissue to compare with pathology and outcomes

  This registry will test whether high-resolution PET-CT scans of removed tumor tissue using the XEOS AURA 10 match pathology results and help guide care and long-term outcomes for adults having cancer surgery.

  Recruiting at 4 sites XEOS Medical · Aalst and 4 other locations · NCT06970275

• Online and in-person exercise programs for cancer survivors in Canada

  This study is testing whether online and in-person exercise programs can help cancer survivors in Canada stay active and improve their health.

  Recruiting at 5 sites University of Calgary · Calgary, Alberta and 4 other locations · NCT06960291

• Early‑phase KESONOTIDE™ treatment for solid tumors

  This trial tests an oral drug called KESONOTIDE™ (a vimentin inhibitor) to see if it is safe and tolerable in adults with advanced or metastatic solid tumors like prostate, breast, lung, ovarian cancer, or glioblastoma.

  Recruiting at 3 sites Phase 1/2 Filamon LTD · Kogarah, New South Wales and 2 other locations · NCT06926075

• Robotic Prostatectomy Pain Reduction with Two Insufflation Devices

  This trial tests whether two different pneumoperitoneum devices used during robotic prostatectomy affect pain after surgery in men with prostate cancer.

  Recruiting East and North Hertfordshire NHS Trust · Stevenage, Hertfordshire · NCT06915909

• Extended versus no pelvic lymph node removal during radical prostatectomy

  This trial tests whether removing more pelvic lymph nodes during prostate removal surgery helps men with high‑risk prostate cancer who have no metastases on PSMA‑PET.

  Recruiting at 15 sites University Hospital, Basel, Switzerland · Aarau and 14 other locations · NCT06776172

• AI blood test using platelet and immune-cell RNA for early cancer detection and monitoring

  This AI-based blood test profiles platelet and immune-cell RNA to see if it can find common cancers early and track treatment response in adults aged 40 and older.

  Recruiting at 2 sites Dysplasia Diagnostics Limited · Rosario and 3 other locations · NCT06717295

• Using Ivocizumab to treat various advanced rare tumors

  This study is testing if a new treatment called Ivocizumab can help people with different types of advanced rare tumors feel better and live longer.

  Recruiting Phase 2 Fudan University · Shanghai, Shanghai Municipality · NCT06683846

• Evaluating prostate cancer using FAPI PET/MRI scans

  This study is testing if a special type of scan can help doctors better diagnose and monitor prostate cancer in patients who already have the disease.

  Recruiting Phase 2 University of Wisconsin, Madison · Madison, Wisconsin · NCT06675357

• FK-PC101 vaccine for men with high-risk prostate cancer after surgery

  This study is testing a new vaccine for men with high-risk prostate cancer after surgery to see if it can help prevent the cancer from coming back.

  Recruiting at 2 sites Phase 2 Cellvax Therapeutics Inc · Chicago, Illinois and 2 other locations · NCT06636682

• Calibration-powered MRI for Prostate Cancer: Enhanced Diffusion Measurements

  This study tests whether the CARE Phantom system can improve the consistency of MRI-based diffusion measurements in men undergoing MRI for suspected prostate cancer.

  Recruiting Gold Standard Phantoms · London, London · NCT06607783

• Digital health coaching for cancer survivors

  This study is testing whether a digital health coaching program can help cancer survivors feel better and improve their health after finishing treatment.

  Recruiting at 2 sites Pack Health · Gainesville, Florida and 6 other locations · NCT05349227

NIH-funded research (10)

Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.

• Ariginine-depleting therapy plus chemotherapy for aggressive variant prostate cancers

  This project tests whether removing arginine from the body enhances chemotherapy for men with a difficult-to-treat prostate cancer subtype.

  NIH research University of Tx Md Anderson Can Ctr · Houston, United States · NIH-11391400

• Targeting master regulators to overcome AR-driven resistance in advanced prostate cancer

  This grant explores how cancer cells rewire their growth signals to resist AR-targeted therapies in advanced prostate cancer and tests new ways to block those master regulators.

  NIH research State University of New York at Buffalo · Amherst, United States · NIH-11369845

• Lowering arginine with chemotherapy for aggressive prostate cancer

  Looks at whether lowering a nutrient called arginine together with platinum‑taxane chemotherapy can help men with aggressive, treatment‑resistant prostate cancer.

  NIH research University of Tx Md Anderson Can Ctr · Houston, United States · NIH-11174404

• Targeting key regulators in advanced prostate cancer that resist standard treatments

  This research looks for new ways to treat advanced prostate cancer that has stopped responding to common hormone therapies.

  NIH research State University of New York at Buffalo · Amherst, United States · NIH-11159586

• Investigating the impact of arginine depletion with chemotherapy in aggressive prostate cancers

  This study is looking at how lowering levels of an amino acid called arginine might make chemotherapy work better for men with aggressive prostate cancer that doesn't respond well to regular treatments.

  NIH research University of Tx Md Anderson Can Ctr · Houston, United States · NIH-10932183

• Targeting DNA repair pathways in prostate cancer

  This study is looking at whether a special combination of treatments can help men with non-castrate prostate cancer, especially those with certain genetic changes, by focusing on fixing DNA damage to improve their chances of recovery.

  NIH research Sloan-Kettering Inst Can Research · New York, United States · NIH-10922777

• Targeting key factors in advanced prostate cancer treatment resistance

  This study is looking at how certain proteins in prostate cancer cells help the cancer resist treatments that target hormones, with the goal of finding new ways to improve treatment for patients who aren't responding to current therapies.

  NIH research State University of New York at Buffalo · Amherst, United States · NIH-10904810

• Targeted treatments for advanced prostate cancer

  This study is testing new treatments for men with high-risk localized prostate cancer that doesn't respond well to regular hormone therapies, aiming to make chemotherapy more effective while reducing side effects, so you can have better outcomes and a lower chance of the cancer coming back.

  NIH research Case Western Reserve University · Cleveland, United States · NIH-10899447

• Understanding how BRCA2 mutations affect prostate cancer treatment responses

  This study is looking at why some prostate cancers with BRCA2 mutations don’t respond well to treatment and how we can improve those treatments, specifically for patients with advanced castrate-resistant prostate cancer.

  NIH research Ut Southwestern Medical Center · Dallas, United States · NIH-10881665

• Investigating unique genetic markers in aggressive prostate cancers among African American patients

  This study is looking at how certain genetic differences might explain why aggressive prostate cancer is more common in African American men, with the hope of finding new ways to improve treatment and care for them.

  NIH research University of Maryland Eastern Shore · Princess Anne, United States · NIH-10466902

Related topics

Quick answers

How many Prostate Cancers clinical trials are recruiting right now?

11, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 11 countries. The most sites are in United Kingdom (4 trials), United States (3 trials), Australia (1 trial), Canada (1 trial), Belgium (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 3, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →